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ABSTRACT
It is known that the body can efficiently repair hard tissue (bone) micro fractures by
suturing the defect through the deposition of minerals resulting in an area that is stronger postinjury. Larger defects, however, generally cause more trouble since the body is incapable of
repairing them. Bone defects can occur as a result of congenital abnormalities, trauma, or
disease. Traditional methods for addressing these defects have involved the use of acellular
cadaverous bone or autologous bone. Both contain innate problems associated with them; the
former method can result in disease transmission, as well as very low integration with the host
due to the lack of viable cells while the latter is associated with two surgical sites and morbidity
at the donor site. Alternative methods have been developed, but no method has yet provided a
satisfactory solution. As a result, researchers and the medical community are turning toward the
promising fields of biomaterial development and tissue engineering to develop new materials and
methods of bone regeneration.
In this work, a design of experiments (DOE) approach was performed to render
commercially

available

biodegradable

polymers

(Poly(caprolactone)-diol/triol)

photocrosslinkable and resultantly manufacturable using stereolithography (SL), a rapid
prototyping technology. To perform the investigations, a commercial SL system (Viper HA, 3D
Systems, Valencia, CA) equipped with a solid state laser system (355 nm wavelength) was used
to manufacture synthesized poly(caprolactone) trifumarate (PCLtF) 3D porous constructs.
Results of the work conducted produced constructs which provided promising chemical
and biological results for the intended application.
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CHAPTER 1
INTRODUCTION
1.1

Background
Recent advancements in the area of tissue engineering and the development of porous

three-dimensional (3D) implantable scaffolds for tissue regeneration have placed a greater
demand on the need for novel biomaterials which exhibit more desirable properties, as well as
lend themselves to be modified for a specific application. Traditional methodologies such as
salt/porogen leaching have been extensively studied and employed in the “manufacture” of
porous scaffolds [2-5], but several limitations exist; namely, lack of control of uniform pore
dispersion, pore geometry, pore size, and interconnectivity all of which are necessary for
successful integration of the 3D scaffold with the host [6-8].
Rapid prototyping (RP) technologies provide a means of addressing the aforementioned
limitations of traditional methods through the development of novel biomaterials tailored to a
specific RP technology resulting in constructs with desirable and designable properties necessary
for their application.

One such RP technology that is currently being investigated is

stereolithography (SL).
Stereolithography is a RP technology that can be used to manufacture 3D scaffolds for
tissue engineering applications due its capability of producing highly accurate 3D parts. The
parts are created by, polymerizing or photocrosslinking a resin with an ultraviolet (UV) laser that
cures/solidifies the resin in a layer-by-layer process until the part is completed. Even though the
scientific community has shown signs of distancing themselves from this particular RP
technology no other technology has shown the resolution, accuracy and control of 3D internal
and external architecture that can be achieved by SL.
1

The development of novel polymeric biomaterials that can be manufactured using RP
offers engineering advantages, including enhanced biocompatibility, biodegradability, and
bioactivity. Current research related to polymeric biomaterials involves studies of ways in which
these materials can be modified to making them more suitable for specific applications. One
such modification would be the addition of reinforcement nanocomposites such as
hydroxyapatite with regards to hard tissue defects [9-13]. Physically altering the chemical
composition of the polymer is another modification utilized in the SL process for the purpose of
improving manufacturability. Research and development in these areas are likely to become
even more important as technology changes and the biomedical industry continues to demand
new materials with improved properties to address specific patient needs.
The approach taken to chemically alter the molecular composition of polymeric
biomaterials is critical as much of the physical and mechanical properties of the synthesized
material are predicated on the chemical composition of the polymer. With regards to polymeric
biomaterials, one key determinant of mechanical properties is molecular weight with stiffness
increasing as a function of molecular weight. In addition, solubility decreases with increasing
molecular weight, therefore chemical modification of polymeric biomaterials must be planned
according to the RP technology to be used. Low molecular weight materials are most suited for
manufacture via SL due to the fact that the SL process manufactures from a photocrosslinkable
liquid resin. For this reason, it is key to render the candidate material photocrosslinkable while
maintaining a relatively low molecular weight.

2

In addition to manufacturability; biocompatibility, degradability and bioactivity are
properties that can be addressed via chemical modification through the incorporation of
functional side-/endgroups to the polymeric backbone.

Biocompatibility is an important

characteristic for successful implantation of 3D TE constructs.

It is nearly impossible to

introduce a foreign body/material to the physiological system without eliciting a host response,
but through chemistry the severity of host response can be controlled through the encapsulation
or adsorption of proteins, growth factors, or pharmaceuticals [14-18].

Degradability and

bioactivity are of equal concern and are critical components that are currently being investigated
with regards to implantable polymeric biomaterials [19, 20]. Modes of degradation (bulk or
surface) and degradation rates can be controlled by altering the molecular weight of the
synthesized polymer and can be tailored to the end application.

3

1.2

Thesis motivation
Recent advances in biomaterials have played a significant in the development of

biologically relevant implantable three-dimensional (3D) constructs for tissue engineering (TE)
applications manufactured through the use of rapid prototyping (RP) technologies. A few RP
technologies have been exploited as possible candidate technologies for said application with the
final goal of manufacturing custom commercialized implants. Stereolithography (SL) being the
oldest has been used extensively to manufacture prototypes.

It is only natural that this

technology which was originally created to build prototypes now be required to manufacture
functional end-use parts especially with regards to custom implantable 3D constructs. Suitable
biomaterials that are used in RP must be able to provide the qualitative performance that is
required for TE. These constructs must exhibit adequate and reproducible performance in
regards to their dimensions and properties (biocompatibility, degradation, and bioactivity). SL
has the potential of building highly accurate parts with a superior surface finish. For this reason,
SL is a fine candidate for the advancement of functional 3D constructs. The desire to develop
custom 3D constructs from a novel photocrosslinkable biomaterial motivated the current study.

1.3

Thesis goals and aims

The overall goal of this research is to manufacture and qualitatively examine a novel
photocrosslinkable polymeric biomaterial for use in hard tissue defect repair. The goals for the
work presented herein are as follows:
1. The development and extension of a synthesis methodology rendering commercially
available biodegradable polymeric biomaterials photocrosslinkable.

4

2. The manufacture of a computer-aided designed (CAD) porous scaffold via
stereolithography using the aforementioned material.
3. The qualitative examination of CAD manufacture porous PCLtF disks seeded with rat
marrow stromal cells (RMSCs) as a candidate substrate for hard tissue repair.

1.4

Thesis specific objectives

The objective of this study is to extend an established methodology for the synthesis of
photocrosslinkable

polymeric

biomaterials

to

commercially

available

biodegradable

poly(caprolactone) (PCL) for the manufacture of 3D TE constructs for bone regeneration.
Qualitative examination of cell seeded PCL-based constructs is conducted to determine
biocompatibility. The specific project objectives for this study are as follows:
1. Synthesize photocrosslinkable poly(caprolactone)-based biodegradable polymers for
tissue engineering applications.
2. Manufacture three-dimensional (3D) scaffolds with controlled internal and external
geometry using stereolithography.
3. Qualitatively examine biocompatibility and bioactivity on statically cultured 3D
scaffolds.

5

1.5

Thesis outline
The work presented herein is separated into the following chapters. Chapter 2 includes a

literature review of biomaterials as they pertain to bone regeneration with an emphasis on the
candidate material used in the presented work, (poly(caprolactone)) (PCL), as well as traditional
and rapid prototyping technologies that have been employed in manufacturing porous PCL-based
3D TE constructs. A brief overview of RP is presented with emphasis on the stereolithography
(SL) process.

Discussion of current research involving synthesis methodologies and

manufacture of photocrosslinkable PCL is presented as well.

Chapter 3 provides the

experimental setup and synthesis methodology employed in the synthesis of poly(caprolactone)
fumarate/trifumarate (PCLF/PCLtF) as well results of the chemical and physical properties of
synthesized.
constructs.

Chapter 4 explores the manufacture of three-dimensional (3D) PCLF/PCLtF
Degradability and pH studies are presented and discussed in Chapter 5.

Cell

harvesting and culture, cell adhesion and biocompatibility of stereolithography manufactured
porous PCLtF disks are presented in Chapter 6. Lastly, summary of experiments, conclusions,
and recommendations on the future research work are covered in Chapter 7.

6

CHAPTER 2
LITERATURE REVIEW
2.1

Introduction
This chapter begins with an introduction to biomaterials currently employed in bone

regenerative studies, as well as a literature review of poly(caprolactone) (PCL) and discussion on
rapid prototyping (RP). An overview on the different types of RP technologies with emphasis on
stereolithography (SL) is covered. Limitations of currently employed RP technologies as they
pertain to the manufacture of PCL-based constructs will also be discussed.

2.2

Biomaterials for bone regeneration
It is known that the body can efficiently repair hard tissue (bone) micro fractures by

suturing the defect through the deposition of minerals resulting in an area that is stronger postinjury. Larger defects, however, generally cause more trouble since the body is incapable of
repairing them. Bone defects can occur as a result of congenital abnormalities, trauma, or
disease. Traditional methods for addressing these defects have involved the use of acellular
cadaverous bone or autologous bone. Both contain innate problems associated with them; the
former method can result in disease transmission, as well as very low integration with the host
due to the lack of viable cells while the latter is associated with two surgical sites and morbidity
at the donor site. Alternative methods have been developed, but no method has yet provided a
satisfactory solution. As a result, researchers and the medical community are turning toward the
promising fields of biomaterial development and tissue engineering to develop new materials and
methods of bone regeneration.
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Tissue engineering is a hugely multi- and interdisciplinary field involving the
development of novel biomaterials which can be implanted for the purpose of fostering tissue
remodeling with the purpose of repairing or enhancing tissue or organ function. Bioartificial
constructs generally consist of cells and biomaterials, so tissue engineering draws from both
biological and biomaterials science and technology. Successful applications require a good
understanding of the environment experienced by cells in normal tissues and by cells in
bioartificial devices before and after implantation. This chapter reviews these topics, as well as
the current status and future possibilities in the development of bioartificial constructs as they
apply to bone regeneration. Issues that need to be addressed in the future are also discussed.
These include, but are not limited to, the development of new cell lines and biomaterials, the
evaluation of the optimal construct architecture, and the reproducible manufacture and
preservation of bioartificial devices until ready for use.
Bone is a very dense, specialized form of connective tissue. The bone matrix consists of
type I collage and calcium phosphate in the form of hydroxyapatite. A compact, dense cortical
layer (compact bone) comprises the outer region of long bones, while trabecular bone
(cancellous bone) fills the interior. As seen in Figure 2.2.1, the major structural component of
compact bone is called an osteon. Composed of a concentric lamellar matrix, osteons create
cylindrical conduits known as Haversian canals, which provide access for the circulatory and
nervous systems. The capillaries within the Haversian canals originate from arteries and veins
within the marrow cavity. The Volkmann’s canals, which are transverse to the Haversian
system, provide the pathway for bone nourishment. With the exception of articulating surfaces,
cortical bone is surrounded by a thin connective tissue, the periosteum, which consists primarily
of a collagen-rich fibrous layer and osteoprogenitor cells.

8

Figure 2.2.1. An illustration of the structure of cortical bone bone
(http://upload.wikimedia.org/wikipedia/commons/3/34/Illu_compact_spongy_bone.jpg).

Figure 2.2.2a illustrates the structure of trabecular or cancellous bone. As the name
implies, cancellous bone consists of a lattice-like structure comprised of trabeculae, which are
small beams of bone surrounded by marrow. A more detailed image of trabecula can be seen in
Figure 2.2.2b. Within each trabecula, osteocytes maintain bone matrix, osteoclasts degrade
regions of existing structure, and osteoblasts actively build new sections of bone into the
interconnecting marrow spaces [21]. The regeneration of bone tissue involves not only the
synthesis of hydroxyapatite rich collagen scaffolding, but also the recreation of an intricate
structure that lends itself to sensation and mechanical stability.

Figure 2.2.2. (a) A cross-section of a vertebral body illustrating the structure of cortical and cancellous bone. (b) A
more detailed diagram of bone remodeling
Images adopted from (a) http://www.amacmeonline.com/osteo_mgmt/module03/images/m3_02path_02.jpg,
(b)http://www.roche.com/pages/facets/11/bone_remodelling2.jpg.
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As with all materials implanted into the body, polymers for bone regeneration must be
biocompatible. In addition, these materials should be customizable to ensure a good fit in the
defect area and manufacturable to become commercially available. They should support cellular
adhesion and growth, maintain cellular differentiation, provide a porous matrix through which
nutrients and wastes can easily diffuse and degrade into biocompatible byproducts. It is also
crucial that these materials have mechanical properties similar to native bone. Human long
bones (i.e. femur, humerus, radius) typically has a compressive strength of around 135 MPa and
a modulus of 18 GPa [22]. It is imperative that the material maintain its mechanical properties as
it degrades until the newly regenerating tissue can adequately support loading.

If it fails

mechanically, the materials may lead to failure. On the other hand, if the material is too strong it
may cause stress shielding resulting in resorption of the existing tissue and lead to premature
osteoporosis. Finally, the biomaterial should withstand standard sterilization procedures and
have a long shelf life.
Several approaches, including nonpolymeric ones, have been investigated to replace
injured or degenerated bone. Titanium knee and hip implants and poly(lactic-co-glycolic)acid
(PLGA) screws have both experienced good success. These materials, however, do not have the
same mechanical properties as bone and as a result, cannot be used for long-term implants. For
example, since they are much stronger than bone, metallic implants tend to promote the
phenomena known as stress shielding, which leads to the erosion of the surrounding native bone.
Over time, the implant loosens due to the mechanical mismatch resulting not only in pain and
suffering for the patient, but also the need for additional surgical procedures to replace the
malfunctioning implant. Materials that have mechanical properties closely matching those of
native bone would eliminate the problems associated with stress shielding and would provide
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enough strength to support the mechanical strains of weight bearing while new tissue develops.
In the search for such materials, polymers remain attractive candidates since they can be
designed to have a great variety of elastic moduli, including those close to cortical bone.
While designing these materials, scientists and engineers cannot forget that upon
implantation the surface of the polymers will be immediately exposed to the physiological
environment. In vivo, proteins will rapidly cover the surface of any material and tend to
denature on the surface due to the thermodynamic driving forces. Following this phenomenon,
we then have little control over the properties of the surface. At the same time, however, we
must be sure that the materials still are conducive to cell binding, proliferation, and maintenance
of cellular phenotype. Several studies based on the topography of the surface of materials and
cell adhesion have shown that surface roughness does play a role in cell adhesion [23-25]. This
interaction indicates that as we attempt to optimize other design criteria, we must also properly
design surfaces to influence the behavior of cells.

2.3

Polymeric biomaterials
The proceeding discussion will examine polymeric materials that are being utilized for

bone regeneration.

Initially, examples involving the control of surface chemistry and

morphology to guide cell adhesion, morphology and differentiation will be examined followed
by an examination of research that attempts to adapt materials approved by the US Food and
Drug Administration (FDA).

Finally, materials with mechanical and erosion properties

favorable for bone regeneration will be discussed.
Surface modification techniques have been actively studied for all aspects of tissue
regeneration. It may be possible to modify the surface of a material to force cell specific
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adhesion while designing the bulk materials characteristics not only to guide adherent cells along
a path of tissue regeneration, but also to provide the mechanical stability necessary for continued
tissue use. In one example, metal oxide surface were modified with the cell adhesive peptide
RGD (argining-glycine-D-aspartic acid) and FHRRIKA, a heparin binding domain (HBD) from
bone sialoprotein [26]. Table 2.2.1 lists the names of the amino acids and their one-letter
abbreviations. The surface was first modified with an organosilane followed by coupling of
maleiimide functionality for direct peptide attachment through cysteine thiols. The group then
coupled various rations of RGD:HBD to the surface and seeded rat calivary osteoblast-like cells
on the materials. An RGD:HBD of 75:25 was ideal for mineralization of the surface. Regarding
cell adhesion, the α2β1 integrin receptor played a crucial role in cell adhesion for seeding times
lasting less than 30 min; αvβ1 was involved for longer time points.
Table 2.3.1. A list of amino acids and their abbreviations.

This difference in integrin involvement may signify a way to design surfaces for
osteoblast specific adhesion over controlled times. Many polymers contain functional groups
along the backbone that can be readily functionalized with small bioactive peptides, such as
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RGD. The polymer backbone can then provide mechanical stability and the properties governing
shape designation, while the peptides supply bioactive signals for bone regeneration.
Researchers have found that the surface plays a large role not only in the initial adhesion,
but also in the activity and differentiation of osteoblasts.

Yamamoto et al. looked at

polyethylene terepthalate (PET), acrylic acid/methacryloyloxyethyl phosphate modified PET
surfaces, and the latter surface coated with either collagen or hydroxyapatite (HA) [27]. Rat
bone marrow cells were seeded on each of these surfaces and cultured in vitro for 2 weeks.
Imaging with TEM, the authors saw little cell adhesion to the PET alone. However, both the
phosphate containing polymer surface and the collagen surface supported osteoblast adhesion
and the formation of thin, dense layers of HA juxtaposed to the substrate surface. The HAcoated surface also supported cell adhesion with about 10 times more HA deposition; in addition,
the cells were cuboidal in morphology and appeared more osteoclast like. HA is a crystalline
form of calcium phosphate that is known to enhance bone formation, and collage is an adhesive
protein. In this case, collage did support adhesion of cells, but enhanced bone mineral deposition
required HA. Simply varying the chemical nature of a surface affects adhesion and spreading of
many cell types. Webb et al. coated glass surfaces with five different functionalized silanes to
determine the functional effect on cell adhesion, spreading, and migration [28]. They chose
thiol, oxidized thiol, quaternary amine, and methyl functionalized surfaces. When MC3T3-E1
osteoblast-like cells were cultured on the surfaces, the thiol surface supported the greatest
amount of cell adhesion and spreading followed by the oxidized thiol materials. Both materials,
however, allowed the least amount of migration. This result shows a clear inverse relationship
between spreading and migration.
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When designing new materials, we must consider the required degree of spreading for
cell function and the desired amount of migration to completely fill the materials with cells or
extracellular matrix molecules. The time period for cell spreading and migration also should be
compatible with the ingrowth of new blood vessels to support tissue survival. Although they
may yet succeed in achieving these objectives, surface chemistry modifications alone have not
yet offered completely satisfactory solutions. As a result, we must consider cell function and
how to use material design to influence cellular behavior. Deposition of HA demonstrates one
way to ensure that some osteoblasts synthesize mineralized bone. However, other features of the
material, such as the morphology of the surface and the overall structure, remain important
factors that are also crucial design considerations in any endeavor to regenerate bone.
By using surface roughened polystyrene strips, Hatana et al. isolated surface roughness as
a factor which influences osteoblastic differentiation markers [29]. They found that rough
surfaces were more conducive to osteoblastic differentiation than smooth surfaces. They also
found that as the roughness increased to 0.8 µm, the levels of several differentiation markers,
including alkaline phosphatase and osteocalcin, reached a maximum. At surface roughness
values greater than 0.8 µm, marker synthesis declined. Matsuzaka et al. made micro-patterned
materials of polystyrene and poly(lactide) (PLA). The patters contained ridges and grooves of
the same width with quadrants having 1, 2, 5, or 10 µm ridges and grooves; each groove
measured either 1 or 1.5 µm in depth. Rat bone marrow cells were cultured on these materials.
The authors found better cell adhesion and higher HA and alkaline phosphatase synthesis when
cells were seeded on poly(lactide) substrates. In addition, cells attached only to the ridges and
not to the grooves when the ridges and grooves were 1-2 µm in width. In contrast, both 5-10 µm
ridges and grooves supported cell adhesion. Cells attached to PLA surfaces with 1-2 µm width
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ridges and 1 µm deep wells produced the most mineralized extracellular matrix. The depth of
the ridges/grooves played no role in adhesion or cellular metabolic activity. This work indicates
that both substrate material and morphology can control cellular behavior. Certainly, the native
extracellular matrix has a specifically defined morphology and chemistry.
The FDA approved material poly(lactic-co-glycolic acid) (PLGA) can be readily
processed into three-dimensional porous structures. The processing involves formation of PLGA
foam in the presence of salt which leave behind pores when it is leached from the system. Pore
sizes of at least 100 µm are necessary for cell penetration as the average osteo-like cell nucleus
measure approximately 10 µm in diameter. PLGA (75:25) scaffolds with average pore sizes of
150-300 or 500-710 µm were seeded with rat calvarial osteoblasts. Osteoblasts continued to
proliferate for 56 days. At this time point, the cells had invaded the scaffolds to a depth of
approximately 200 µm. The cells stained positively for alkaline phosphatase activity, and the
scaffolds had been partially mineralized. Similar results have been found with rat bone marrow
stromal cells [30]. This data indicates that for small defects, porous OLGA foams may be
suitable for bone regeneration. However, research has not yet shown if this materials will be
suitable for defects greater that 200 µm.
Brekke and Toth tried to consider several factors as they designed a new material for
bone regeneration [31].

They used porous PLGA filled with 750,000 molecular weight

hyaluronic acid (HyA) and bone morphogenic protein-2 (BMP-2). PLGA filled many of the
architectural requirements of the material by mimicking cancellous bone microstructure, while
the HyA provided a viscous scaffold for cell ingrowth, vascular ingrowth and stimulation, and
growth factor storage.

The BMP-2 acted as a stimulant for bone regeneration and was

osteoconductive; however, pockets of HyA did not contain adequate amounts of growth factor.
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As a result, adipose tissue formed in these regions instead of bone tissue. Improved processing
techniques to uniformly distribute growth factors within HyA will be necessary to fully evaluate
this material as a viable candidate for bone regeneration.
Several synthetic and natural polymers have been studied in connection with bone
regeneration. Collagen-polyvinyl alcohol films were coated onto coverslips and crosslinked
either hydrothermally or via gluteraldehyde [32]. These films were then seeded with osteoblasts.
Surprisingly, increased collagen content caused decreased cell attachment and spreading. This
effect likely resulted from the conformation of the collagen during Crosslinking. Free collagen
is mobile and can expose different regions of the collagen molecule. In contrast, crosslinked
collagen suffers from decreased mobility and potentially cryptic cell-binding motifs. It would be
interesting to evaluate similar scaffolding that had been crosslinked to a lesser degree and also to
evaluate the scaffolding in three dimensions since these materials may behave differently in a
three-dimensional configuration. Several studies have shown different biological behavior of the
same cell types when studied on chemically similar three-dimensional and two-dimensional
materials.
Other possibilities of materials that attempt to induce bone formation include blends of
polymers with ceramic materials such as tricalcium phosphate (TCP). Tricalcium phosphate has
been known to enhance bone formation both in vivo and in vitro. Kikuchi et al. combined
poly(lactic acid) with TCP. They found mechanical properties reasonable for bone regeneration
(fracture strength of approximately 50 MPa; Young’s modulus of approximately 5.18 MPa; and
three-point bending of approximately 50 MPa). They also observed that the materials was
nontoxic in the presence of MC3T3-E1 cells obtained from mouse osteoblasts [33].
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Zhang and Ma have tried to improve the bone bonding ability of porous PLA scaffolds by
growing a layer of hydroxyapatite (HA) on the surface of the three-dimensional foams [34].
They created a PLA scaffold with a porosity of up to 95% by using a liquid-liquid extraction
technique with DMSO. The scaffolds were then dipped into simulated body fluid and HA
crystals formed on the surface of the scaffolds. Crystals grew within all of the porous surfaces.
These crystals may offer an advantage to the materials since many experiments have shown that
HA improves bone bonding to surfaces. Ma et al. also produced PLA/HA composites and
cultured osteoblasts with the materials. They found that osteoblasts migrated further into the
composite materials and had higher survival rates on the composites than on PLA alone. In
addition, bone specific markers were expressed in higher amounts in the composite than in PLA
over a 6-week time period [35]. Murphy, Kohn and Mooney take a similar crystallization
approach to combining calcium phosphate with PLGA scaffolding. They form the porous PLGA
by a combined solvent casting and particulate leaching process. The porous scaffolding is then
placed in a simulated body fluid to encourage the deposition of a mineral layer on the surface.
After 16 days in the simulated body fluid, a mineral layer had formed on the scaffolding, which
increased the compressive modulus five-fold (~250 kPa) [36].

Although significant, this

increase in modulus falls short of the known modulus of trabecular bone [37].
In another method that takes advantage of the bone enhancing capabilities of calcium
phosphate,

Daculsi

et

al.

developed

a

biphasic

calcium

phosphate

(BCP)/methylhydroxypropylcellulose composite as an injectable bone regeneration material.
The ratio of BCP:polymer was 60:40. Short time implantation in rabbits showed a decrease in
density of the synthetic material surface with increased bone formation and no observation of an
inflammatory response. After 12 weeks, 79% of the total surface area was occupied by newly
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formed bone and residual BCP grains. Due to its porous nature, this bone substitute allowed
cells injected within the composite to invade the scaffolding and begin the process of bone
regeneration. As the methylcellulose diffuses out of the material over time, it leaves a space for
the newly formed bone [38]. Initial studies of this material show promise and bode well for
future use of composite materials in bone regeneration applications.
Kasuga et al. has developed a HA fiber/PLA composite that shows improved modulus of
elasticity of PLA alone while maintaining a similar bending modulus. The fibers were 40–150
µm long and 2–10 µm in diameter. During the studies, the composite materials showed an
increase in the modulus of elasticity as the total concentration of fibers increased. Beyond
blends composed of 60% fiber, however, the bending modulus begins to decrease, and brittle
fractures can occur. The authors measured a modulus of 10 GPa with 60% fibers in the
composite, while PLA alone exhibited a modulus of elasticity of 2–7 GPa. The composite
modulus falls well within the range seen in cortical bone [39].
While continued work with FDA approved polymers remains critical and necessary as a
path toward rapid approval of improved implant materials, these materials may not contain the
optimal properties for tissue regeneration. In fact, years of research confirm this observation.
There exists a great need for the design and synthesis of new materials, which are not off-theshelf materials, but materials that have been engineering to meet the constraints imposed by the
tissue of interest. In this vein, several researchers are engineering novel materials for bone
regeneration.
Currently, new, degradable polyurethane materials are being engineered for application in
bone regeneration. Saad et al. have synthesized a material called DegraPol-foam. This foam is
based

on

a

α,ω-dihydroxy-oligo[((R)-3-hydroxybeterate-co(R)-3-hydroxyvalerate)-block-
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ethylene glycol]-co-polymer. They find that osteoblasts will grow on the polymer, remain
differentiated, and proliferate for up to 2 weeks. Degradation of the polymer results primarily in
poly[(R)-3-hydroxybuteric acid] (PHB) and lysine-methylester. These degradation products are
phagocytosed by macrophages and osteoblasts, to some extent, and show no toxicity [40].
Further studies of the degradation products with osteoblasts confirmed the lack of toxicity. The
authors found no change in type I collagen or osteocalcin synthesis (two osteoblast markers)
after 32 days of exposure to the PHB; they did find a time and dose dependent change in alkaline
phosphatase activity. A maximal response of alkaline phosphatase activity occurred after 4 days
exposure to 2 µg PHB [41]. These results not only suggest the usefulness of this type of material
for bone regeneration, but also indicate that the degradation product PHB may actually stimulate
the osteoblasts in a positive manner.
Another promising new materials in Polyactive, a polyethylene oxide-co-polybutylene
terephthalate co-polymer with bone bonding properties [42]. This material exhibits hydrogel
properties. Within confined volumes and in the presence of aqueous solution, it exerts a pressure
on the confining walls due to frustrated swelling. This pressure can reach as high as 2 MPa.
Large, dry cylinders of Polyactive were implanted, with a tight fit, into goat femora and allowed
to swell; pre-swollen Polyactive was implanted into the contralateral femur. After 3, 9, and 25
weeks, histological data showed good material-bone contact for the dry implants, while the preswollen implants had a layer of soft tissue between themselves and the bone. Improved contact
between the dry implants and bone is attributed to the increased swelling pressure exhibited by
the polymer, which is more likely to cause the formation of tight junctions between the swelling
polymer and the native tissue [42]. In addition, this pressure may mimic the pressure exhibited
in native bone tissue.
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Materials with surface eroding properties as opposed to bulk degrading polymers have
been characterized frequently as biomaterials.

Once class of surface degrading polymers

consists of poly(ortho-esters). An advantage of these polymers is that as new tissue grows into
the space occupied by the artificial scaffolding, only the surface of the polymer scaffold
degrades, leaving the bulk of the materials with its original mechanical integrity. With respect to
bone, this may mean the difference between catastrophic failure of an implant and successful
regeneration of the bone. Andriano et al. have studied the degradation properties of 50:50 PLGA
scaffolding and a poly(ortho-ester) scaffolding coated with gelatin by bathing the materials
within saline over a 6-week period. The PLGA scaffolding lost only approximately 5% of its
weight after 3 weeks, but had lost approximately 37% of its weight after 6 weeks.

The

poly(ortho-ester) eroded in a more linear fashion and had lost about 43 % of its weight after 6
weeks. In addition, in vivo results showed that the bone mineral density of the surface eroding
polymers was 25% higher than that of the 50:50 PLGA at 6 and 12 weeks post-implantation in
rabbit calvarial defects [43]. Solheim et al. characterized the inflammatory response and effect
of bone regeneration of both poly(D,L-lactic acid) and poly(ortho-ester).

They implanted

poly(ortho-ester) or PLA containing demineralized bone particles or demineralized bone alone
into the abdominal muscle of male Wistar rats. The bone particles contained growth factors for
bone regeneration while the polymer supported shape, particle retention, and sustained release of
the bioactive compound. They found that poly(ortho-ester) showed no inflammation and had
little to no effect on bone formation; PLA provoked a chronic inflammatory response and
inhibited bone formation [44].
Poly phosphazenes are also surface degradable materials that have been investigated for
bone regeneration.

Ethyl glycinato p-methylohenoxy modified phosphazenes were used to
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synthesize two-dimensional and highly porous (160-200 µm) three-dimensional scaffolds [45].
MC3T3-E1 cells were cultured on both scaffolds. Cells grown on three-dimensional scaffolds
adhered at higher numbers and proliferated more rapidly than cells grown on two-dimensional
surfaces. In fact, by day 21, they had proliferated throughout the matrix. These materials need
further characterization especially in the areas of mechanical properties and degradation rates, in
order to ascertain whether or not they may serve as viable candidates for bone regeneration.
Other new surface eroding materials include a class of poly(anhydride-co-imide). These
materials degrade into biocompatible products and provide favorable mechanical properties; the
polyanhydrides have well defined surface eroding properties while the polyimides have high
strength and rigidity. Attawia et al. synthesized poly[pyromellitylimidoalanine (PMA-ala):1,6bis(carboxyphenoxy)hexane (CPH)] and studied osteoblast adhesion, proliferation and
differentiation over a 21-day period. They found that the rat calivary osteoblasts behaved
similarly on the PMA-ala-co-CPH as they did on tissue culture polystyrene with respect to
adhesion, proliferation and differentiation over the entire 21-day period. The cells stained
positively for alkaline phosphatase, osteocalcin (an extracellular matrix protein of bone) and
osteopontin (a cellular adhesion protein). This new class of materials can be designed to have
compressive moduli over the range of 10–60 MPa, which is well within the range of calcinous
bone [46]. Muggli et al. have also worked on degradable anhydride-based materials for bone
regeneration. They synthesized a series of polymers with varying ratios of sebasic acid (MSA)
and 1,6-bis(carboxyphenoxy) hexane (CPH). By varying the ratio of the monomers they could
control both crosslink density and degradation rates. For example, they synthesized materials
with degradation rates ranging from 2 days to 1 year and mechanical properties ranging from 1.4
to ~0.14 GPa. In general, the mechanical properties of the crosslinked polymer are similar to
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those of both cortical and trabecular bone. More importantly, due to their surface eroding nature,
these polymers retain 70% of their mechanical integrity when 50% on the materials has eroded
away [47]. As a result of this characteristic, these polymers are likely to maintain required
mechanical properties while degrading at a rate comparable to bone regeneration. Polyanhydride
esters based on siacylic acid monomers also have sparked interest as a potential material for bone
regeneration since the siacylic acid degradation product can be osteoconductive in vivo [48].
This work demonstrates the possibility of using the degradation products of novel surface
eroding polyanhydrides to further induce bone formation.
In addition to the design and synthesis of new materials and further study of existing
materials, researchers are attempting to alter a material’s ability to regenerate bone tissue by
including bioactive molecules. One class of biologically active molecules, which has proven
useful in bone regeneration, involves the bone morphogenic proteins or BMPs. BMPs are active
in other tissue regeneration as well, but some of these compounds, such as BMP-2, are active in
bone formation. Like many biomolecules, BMP-2 exists commercially in recombinant form,
making it a potentially highly useful agent in tissue regeneration. Winn et al. sought to take
advantage of the potency of BMP-2 by combining it with porous PLA coated with type I
collagen. These scaffolds were either preseeded with osteoblast precursor cells or implanted in
Harlan nude athalamic rats without cells. Scaffoldings with BMP-2 significantly induced more
bone production than scaffoldings without BMP-2 [49]. These results are encouraging because
they suggest the possibility of regenerating bone without having to harvest or expand osteoblast
populations from the patient. Peter et al. showed that another growth factor may improve the
success of bone regeneration. They entrapped transforming growth factor-β1 (TGF-β1) in PLGA
microspheres containing 5% polyethylene glycol and studied the effect of the release of the TGF-
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β1 on osteoblasts seeded on poly(propylene fumarate). They found that TGF-β1 significantly
increased the proliferation of osteoblasts, alkaline phosphatase activity, and osteocalcin
production after 21 days in culture in comparison to cells seeded on poly(propylene fumarate) in
the absence of TGF-β1 [50].
It may be possible to use some of the newly designed polymers in combination with
bioactive molecules, e.g. BMP-2 and calcium phosphate derivatives, to produce scaffolding
materials that will provide all of the requirements mentioned at the outset of this discussion.
These requirements include, among others, mechanical attributes similar to those of native bone,
pliability to fit the defect, and regenerative properties. Certainly, the mechanical properties
obtained with some of the surface eroding polymers show considerable promise, as they are
similar to native bone. In addition, using surface erosion as the primary mode of degradation
may allow the synthetic bone scaffolding to maintain mechanical integrity until sufficient natural
bone has replaced the defect.
Additional reviews on polymeric biomaterials for bone regeneration are available. A
recent review by Hutmacher details polymeric biomaterials and discusses in vitro bioreactors for
proper tissue development. The review also contains a table showing time dependent polymer
degradation profiles as well as the amount of time that a polymer will maintain its respective
mechanical properties in vivo. The actual mechanical properties, however, are not given [51].
Middleton and Tipton have reviewed the use of poly(lactide), poly(glycolide) and
polycaprolactone and their blends as orthopedic biomaterials. Their review includes mechanical
properties, degradation rates and commercial uses of these polymers [52]. Temenoff and Mikos
review injectable polymers and ceramics for bone and cartilage regeneration. They include
mechanical properties, chemistries and modes of crosslinking, and they also discuss regeneration
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efficacy of the materials [53]. This discussion attempts to compliment the information given in
the above-mentioned articles and does not attempt to include all information regarding bone
regeneration, but merely introduce the breadth of the area of study for this work.

2.3.1 Poly(caprolactone)
Poly(caprolactone) (PCL) is a semicrystalline aliphatic polyester which exhibits adequate
chemical and mechanical properties making it a suitable candidate material for bone regenerative
focused research. Poly(caprolactone) and PCL-based composite materials have been widely
investigated as candidate biomaterials for bone regeneration due to their mechanical properties,
miscibility with other polymers and, to a certain extent, degradability. In addition, native PCL
and functionalized PCL have become commercially available and are currently marketed as a
Federal Drug Administration approved biodegradable polymer.
As discussed in the previous section, much work has been focused on the development
and extension of well characterized and novel polymeric biomaterials for bone regeneration. A
recent review by Labet and Thielemans provides a concise introduction to the base material of
this work including physical properties (as shown in Table 2.2.2) and modes of synthesis [54].
Certain limitations exist in terms of manufacturability and degradation rate of PCL which are
directly related to the molecular weight of the material. With regards to manufacturability, PCL
in its native form is limited in terms of the manufacturing processes by which 3D constructs may
be formed, therefore chemical modification of native PCL is required for certain technologies.
Degradation studies have been performed by researchers such as Lam who has reported
extensive work regarding hydrolytic degradation and the respective degradation rates of PCL and
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PCL-based composite materials[55-59]. Hakkarainen has performed studies regarding biotic
and abiotic mechanisms of degradation on PCL [60, 61].
Table 2.1.2. Properties of PCL as adopted from Labet and Thielemans [54].

As is shown in Table 2.2.2 PCL has been synthesized in a wide range of molecular
weights with varying physical and mechanical properties. Unfortunately, high molecular weight
PCL is limited in terms of usable manufacturing technologies for 3D construct fabrication due to
its high melting temperature resulting in the necessity of halogenated or polar solvents. Low
molecular weight PCL (<900 Da) remains liquid at ambient temperature making it better suited
for manufacturing by RP, particularly stereolithography.

2.4

Rapid prototyping
Rapid prototyping (RP) is a layered manufacturing technique that utilizes a 3D computer

aided design (CAD) model to construct the 3D model through a myriad of technologies. The 3D
model is sectioned into a series of layers which is then converted to a format, typically .STL,
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which is then read by the RP apparatus and manufactured. Manufacture is done on the z-axis.
After a layer is constructed, a new layer of material is exposed on top and a new layer is built.
Post-processing of the manufactured part may be required [62]. The particular RP technology
used to form the layer, its thickness, and how well the part is represented in the CAD model,
contribute to the effectiveness to duplicate desired 3D complex parts [63]. The advancement to
rapid manufacturing (RM) will mainly depend on cost and productivity improvements which
have to include other technical progressions in material properties and most importantly accuracy
and reliability [64, 65].

2.4.1 Stereolithography
One of the oldest and most widely used rapid prototyping technologies is
stereolithography (SL) illustrated in Figure 2.4.1. SL is capable of manufacturing geometrically
complex parts exhibiting an equivalent surface finish to that of conventionally machined
components. SL manufactured prototypes are often used as masters to produce silicone molds
for vacuum or injection molding [66]. The SL process functions by photopolymerization. This
technique employs a laser beam to selectively draw or print cross-sections of a model on a
photocurable resin surface which is repeated on the surface of the resin in a layer-by-layer
method until a 3D part is created.
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.
Figure 2.4.1. Viper Si² stereolithography
apparatus

A solid computer aided design (CAD) model of the desired construct is first created using
CAD software and is then converted to a file format known as .STL (stereolithography) which is
required to direct the laser as to what is to be drawn. The file format originated from 3D
Systems. The .STL file format has been successful because of its sufficiency and its simplicity.
It is sufficient mathematically because it is able to describe a solid object using a boundary
representation (B-rep) technique. An .STL file format represents the CAD model of the object to
be prototyped as a collection of triangular facets; when taken together, the triangular facets
describe a polyhedral approximation of the object’s surface which is nothing more than a list of
x, y, and z coordinate triplets that describe a connected set of triangular facets[67].
Once the SL machine receives the instructions from the .STL file it is ready to begin
fabricating the solid part. Figure 2.4.2 demonstrates the main components of the SL machine.
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An ultraviolet (UV) laser beam is directed by a computer-controlled optical scanning system
across the surface of a liquid resin containing vat to selectively solidify the liquid photopolymer.
The laser draws each layer of the part from the information provided by the CAD build data file.
As the laser beam makes contact with the resin the liquid is partially solidified. After a layer is
completed, the supporting platform is lowered by an amount equivalent to the thickness of one
layer covering it with the resin that is contained in the vat. The surface is then recoated and
leveled with resin to help establish the thickness and flatness of the liquid layer. As each layer is
drawn, it adheres to the previous layer that was completed to begin forming the solid part as
shown in Figure 2.4.3 [68]. After the process is repeated to the desired part dimensions, the
platform on which the part was fabricated rises out of the liquid resin to expose the completed
part that had been submerged in the resin during the building process.

Figure 2.4.2. SL schematic with components [1]
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Figure 2.4.3. Process for recoating [67]

After the building process the fabricated part is not completely solidified, therefore the
part undergoes a clean and post-curing procedure to remove unwanted uncured resin. Once the
uncured resin is removed from the fabricated part it is placed into a UV oven to promote
complete photopolymerization [69-71].
2.4.1.1

Photopolymerization
Stereolithography uses a photopolymerization process to turn a liquid resin into a solid

part. Photopolymerization is defined as the linking of small molecules (monomers) into larger
molecules (polymers). Typical polymers may consist of hundreds of thousands of monomeric
components of varying molecular weights.

Liquid photopolymers can be solidified by

electromagnetic radiation whose wavelengths may include γ-rays, X-rays and UV. Most RP
systems including SL systems are curable in the UV range [67].

The dynamics of

polymerization during photopolymerization can fundamentally influence the accuracy of the
fabricated part. Selection of SL resins may be dependent on the evaluation of photopolymers
with respect to these dynamics of polymerization [72].
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CHAPTER 3
SYNTHESIS OF PCLF AND PCLTF
3.1 Introduction
The

following

chapter

documents

the

synthesis

methodology

and

chemical

characterization of poly(caprolactone) fumarate (PCLF) and poly(caprolactone) trifumarate
(PCLtF).

The following sections in this chapter provide specifications on the synthesis

methodology and chemical analysis.

3.2

Materials and Methods

3.2.1 Synthesis of PCLF and PCLtF
Poly(caprolactone) fumarate and Poly(caprolactone) trifumarate were synthesized via a
well documented condensation polymerization reaction used for the synthesis of poly(propylene
fumarate) [73] (Figure 3.2.1). All reagents were obtained from Sigma-Aldrich (Sigma –Aldrich,
St. Louis, MO 63103). It should be noted that DEF and precursor PCL derivatives used in these
experiments are currently approved by the United States Food and Drug Administration as
biocompatible materials, PCL is marketed as a biodegradable polymer. No purification of
reagent materials was conducted. The current synthesis methodology aims at addressing existing
shortcomings as described by Wang, et al. [74] with respect to color and UV
photocrosslinkability, as well as solubility; namely the use of harsh organic solvents due to the
insoluble nature of Poly(caprolactone) at high molecular weights (>2,000 Daltons).
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Figure
Figure 3.2.1.
3.2.1. Schematic
Schematic of
of (a)
(a) Poly(caprolactone)
Poly(caprolactone) fumarate
fumarate synthesis
synthesis and
and (b)
(b) Poly(caprolactone)
Poly(caprolactone) trifumarate
trifumarate synthesis
synthesis
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Figure 3.2.2. Glassware setup used in the synthesis of PCLF and PCLtF.

Figure 3.2.2 illustrates the glassware setup for the synthesis of each respective material.
Figure 3.2.2A displays the three-neck round bottom flask where all reagents are added. The
flask is seated in an oil bath set at 100°C initially and left for 1 hour. The oil temperature is then
raised at a rate of 10°C/hour up to the final reaction temperature (140°C) An overhead stirrer is
used to ensure adequate mixture of reagents and is set at 300 rpm. A key component to the
success of the reaction(s) is a constant vapor temperature (~70°C) which is measured by a
claisen adapter and thermometer (Figure 3.2.2B). The boiling point of ethanol is 70°C. A very
low flow rate (<0.012psi) of nitrogen gas (N2(g)) is fed into the system to prevent oxidation of the
polymer and the ethanol vapor is fed into a condenser (Figure 3.2.2C) which is connected to a
cooling system of chilled water. The flow rate is monitored by a bubble system (Figure 3.2.2D)
and the distilled ethanol is collected and measured in a round bottom flask (Figure 3.2.2E). The
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reactions are allowed to proceed until ~90% (weight) of the calculated distillate (ethanol) is
collected. Vapor temperature is modulated by adjusting the N2(g) flow rate.
Poly(caprolactone) fumarate with a weight-average molecular weight (Mw) of 1,475 Da
and polydispersity index (Mw/Mn) 1.032 was synthesized by a transesterification reaction
wherein poly(caprolactone) diol (Mn = 530) is reacted with diethyl fumarate in the presence of a
metal catalyst (ZnCl2) and proton scavenger (hydroquinone) (HQ) under an inert atmosphere of
nitrogen gas. The amounts of each respective reagent are listed in Table 3.2.1.
Table 3.2.1. Quantities of each respective reagent used in the synthesis of PCLF.

Poly(caprolactone) fumarate synthesis
Reagent

Mol Ratio

Formula Weight (g · mol-1)

Mass (g)

Diethyl fumarate

1

172.18

172.18

Poly(caprolactone) diol

2

114.1

228.2

Hydroquinone (HQ)

0.01

110.11

1.1011

Zinc Chloride (ZnCl2)

0.002

136.28

0.2726

Ethanol (Distillate)

2

46

92

The quantities used in the synthesis of PCLF were based on stoichiometric ratios of DEF
to PCL-diol (2:1) where the fumarate group of DEF is placed in the middle to two PCL polymers
such that an hydrolizable (-OH) endgroup of the PCL-diol is retained for biodegradability. The
progress of each reaction is determined by the mass of collected distillate (ethanol) which is
equivalent to the moles of PCL-diol used in the reaction as PCL is the limiting reagent in this
synthesis.
Poly(caprolactone) trifumarate with a weight-average molecular weight (Mw) of 1,964 Da
and polydispersity index (Mw/Mn) 1.407 was synthesized by a series of two transesterification
reaction wherein poly(caprolactone) triol (Mn = 900) is reacted with diethyl fumarate in the
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presence of a metal catalyst (ZnCl2) and proton scavenger (hydroquinone) (HQ) under an inert
atmosphere of nitrogen gas for the purpose of adding the photocrosslinkable alkene-containing
(C=C) fumarate group. A secondary reaction involving the triester intermediate created from the
first reaction and propylene glycol was conducted for the purpose of adding the hydrolizable (OH) endgroup thus rendering PCLtF biodegradable. The amounts of each respective reagent are
listed in Table 3.2.2.
Table 3.2.2. Quantities of each respective reagent used in the synthesis of PCLtF.

Poly(caprolactone) trifumarate synthesis
Reagent

Mol Ratio

Formula Weight (g · mol-1)

Mass (g)

Diethyl fumarate

3

172.18

516.54

Poly(caprolactone) diol

1

114.1

114.1

Hydroquinone (HQ)

0.01

110.11

1.1011

Zinc Chloride (ZnCl2)

0.002

136.28

0.2726

Propylene glycol

3

76.1

228.3

Ethanol (Distillate)

6
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276

Theoretical yields for each of the syntheses were 5:1 and 2:1 for PCLtF (PCLtF:PCLtriol) and PCLF (PCLF:DEF), respectively. Poly(caprolactone) triol is the limiting reagent in the
synthesis of PCLtF and DEF is the limiting reagent for PCLF synthesis.

Actual yields

approximated that of the calculated theoretical values.

3.2.2 Fourier-transform infrared spectroscopy
All reagents, synthesized PCLF and PCLtF, as well as the PCLtF triester intermediate
were analyzed by Fourier-transform infrared spectroscopy (FT-IR) (Perkin Elmer Spectrum 100
FT-IR Spectrometer, Perkin Elmer, Waltham, MA 02451) using a salt plate. Sodium chloride is
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“invisible” at the infrared range of the spectrum. The salt plate was washed with acetone prior to
each analysis.

FT-IR analysis exploits the oscillating frequencies of bonded molecules to

characterize functional groups based on mass differences; the oscillating frequencies of the
molecule provide a fingerprint of the molecule. Figure 3.2.3 shows the FT-IR utilized in the
chemical characterization of synthesized PCLF and PCLtF.

Figure 3.2.3. Fourier-transform infrared spectroscopy instrument used for chemical characterization of synthesized
PCLF/PCLtF.

3.2.3 Molecular weight/polydispersity determination
Molecular weight analysis and polydispersity index determination were conducted by gel
permeation chromatography (GPC) (Viscotek GPCMax/TDA, Malvern Instruments Ltd.,
Worcestershire, United Kingdom). GPC is a size-exclusion based chromatographic technique
wherein the dissolved analyte is injected in-stream with the mobile phase separated by an air
bubble (Figure 3.2.4a). The refractive index of the analyte is compared with the refractive index
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of the solvent (mobile phase) upon passage through a porous silica column where larger particles
matriculate first through the column and smaller molecules are impeded by the porous silica
(Figure 3.2.4b). Figure 3.2.4c illustrates the separation of analytes and a typical chromatogram
wherein the sharpness of peak corresponds to the polydispersity of the analyte and the integral is
related to the molecular weight. Polystyrene (PS) standards of varying molecular weights (2,000
– 25,000 Daltons) were analyzed for calibration of the instrument. Typically, PS standard
solutions (<25mg/mL) used in the analysis were unfiltered due to the relative purity of the
sample. Tetrahydrofuran was used as the organic mobile phase and dissolved PCLF/PCLtF
samples were diluted in varying concentrations (<250mg/mL) and filtered through a 0.2 µm
syringe filter prior to analysis.

Figure 3.2.4. Gel permeation chromatography principle of size exclusion and typical chromatogram.

3.3

Results
Synthesized Poly(caprolactone) fumarate (PCLF) and Poly(caprolactone) trifumarate

(PCLtF) as shown in Figure 3.2.1 were chemically characterized using Fourier-transform
infrared spectroscopy (Perkin Elmer Spectrum 100 FT-IR Spectrometer, Perkin Elmer, Waltham,
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MA).

Molecular weight and polydispersity index determination were conducted by gel

permeation chromatography (GPC) (Viscotek GPCMax/TDA, Malvern Instruments Ltd.,
Worcestershire, United Kingdom).
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3.3.1 Fourier-transform infrared (FT-IR) spectroscopy results and discussion
Poly(caprolactone) fumarate
Poly(caprolactone) fumarate was synthesized by the same methodology used in
synthesizing PCLtF. Two PCLF derivatives were synthesized and analyzed by FT-IR. The
purpose of the experiment is to incorporate a photocrosslinkable alkene (C=C) between two PCL
molecules. Unlike the two-step PCLtF reaction, only one reaction was conducted as one of the
primary alcohols present in the PCL-diol molecule was retained for biodegradability. PCL-diol
is an aliphatic polyester so named due to the two primary alcohol endgroups containing hydroxyl
endgroups (-OH) present. Two PCL-diols of nominal weight (Mn ) 530 Da and 1250 Da were
used, respectively. PCL530 exhibits a less viscose appearance as opposed to PCL1250 due to
the lower molecular weight.
FT-IR spectra of DEF, PCL530, PCL1250, PCLF530, and PCLF1250 are shown in
Figure 3.3.1. Similar infrared absorption ~3500 cm-1 and ~1735 cm-1 are present in both PCLdiols used in the synthesis of PCLF. As in the case of PCLtF, the primary peak of interest with
regards to DEF is that of the crosslinkable alkene (C=C) which is typically seen ~1650 cm-1.
PCLF530/1250 is synthesized through a one-pot transesterification reaction. The reaction is
performed for the purpose of adding flexible hydrolysable PCL groups to a center alkene. The
product yields a photocrosslinkable PCL. FT-IR analysis of synthesized PCLFs illustrates the
presence of the alkene and hydroxyl peaks.
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Figure 3.3.1. FT-IR Spectra of DEF, PCL and synthesized PCLF.
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Poly(caprolactone) trifumarate
Poly(caprolactone) trifumarate was synthesized via a condensation polymerization
reaction.

The purpose of the experiment is to functionalize low molecular weight

poly(caprolactone) (<1,250 Da) by incorporating photocrosslinkable alkene endgroups to the
PCL molecule. In addition to rendering the material crosslinkable, a secondary reaction is
conducted to render the end product biodegradable via hydrolysis.
FT-IR spectra of the two main reagents (Diethyl fumarate (DEF) and Poly(caprolactone)
triol (PCL-triol) are shown in Figure 3.3.2. PCL-triol is so named due to the presence of three
functional primary alcohols containing hydroxyl endgroups (-OH). Infrared absorption by –OH
typically occurs ~3500 cm-1 [75] as indicated in Figure 3.3.2. A secondary PCL-triol peak of
interest is that of the carbonyl (C=O) which absorbs at ~1735 cm-1. The primary peak of interest
with regards to DEF is the crosslinkable alkene (C=C) which is typically seen ~1650 cm-1.
PCLtF is synthesized through a series of two reactions. The first reaction is performed
for the purpose of adding the crosslinkable alkene to the PCL branches. The product of the first
reaction is a PCL-triester intermediate.

FT-IR analysis of the intermediate illustrates a

diminished hydroxyl peak and a detectable alkene peak. The by-product of the both reactions is
ethanol, therefore the diminishing hydroxyl peak corresponds to the distilled ethanol. The PCLtriester intermediate is the limiting reagent for the second reaction.
The second PCLtF synthesis reaction involves the use of the triester intermediate from
the first reaction in addition to a highly used FDA approved biocompatible material, propylene
glycol (PG) (Figure 3.3.3). FT-IR spectral analysis reveals the presence of the hydroxyl group
present in the PG molecule.

PG is reacted with the triester intermediate through a

transesterification reaction for the purpose of adding the hydrolysable hydroxyl functional group
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thus rendering PCLtF biodegradable through hydrolysis. FT-IR spectra of PCLtF reveal the
successful incorporation of the alkene and hydroxyl functional endgroup.
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Figure 3.3.2. FT-IR spectra of PCLtF synthesis reaction 1
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Figure 3.3.3. FT-IR spectra of PCLtF synthesis reaction 2
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3.3.2 Molecular weight/polydispersity results and discussion
Poly(caprolactone) fumarate
GPC analysis of synthesized PCLF (Figure 3.3.4) revealed a molecular weight of 1,475
Daltons with a corresponding PI of 1.032 (Figure 3.3.5).

Figure 3.3.4. Chromatogram of synthesized PCLF.

Figure 3.3.5. Gel Permeation Chromatography results of synthesized PCLF with highlighted Molecular weight and
Polydispersity Index (Mw/Mn).
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Poly(caprolactone) trifumarate
GPC analysis of synthesized PCLtF(Figure 3.3.6) revealed a molecular weight of 1,964
Daltons with a corresponding PI of 1.407 (Figure 3.3.7).

Figure 3.3.6. Chromatogram of synthesized PCLtF.

Figure 3.3.7. Gel Permeation Chromatography results of synthesized PCLtF with highlighted Molecular weight and
Polydispersity Index (Mw/Mn).
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Molecular weight and polydispersity indices affect, to a large extent, many physical and
mechanical properties to include: degradation rate, mode of degradation, manufacturability, and
solubility. Therefore, it is imperative for the scope of this current project to functionalize PCL
while maintaining a manageable molecular weight. The results presented in Figures 3.3.4 - 3.3.7
illustrate molecular weights below the desired maximum of 2,000 Daltons and PI less than 2.0.
A low PI indicates a more uniform chain length which leads to more uniform degradability while
low molecular weight materials degrade at a faster rate.

3.4

Conclusions
We have demonstrated that commercially available low molecular weight PCL can be

functionalized

and

rendered

photocrosslinkable

by

adapting

a

well

documented

polycondensation reaction using FDA approved reagents. The methodology employed lends
itself to be extended to other primary alcohol containing biodegradable reagents thus broadening
the range of materials that can be rendered photocrosslinkable. Also, the elimination of harsh
solvents is an additional benefit which has implications in terms of cell adhesion and
biocompatibility.
Studies utilizing Poly(caprolactone)-based materials have primarily, if not entirely
focused on hard tissue regeneration thus limiting it applicability in terms of regenerative
medicine. It is well known in the scientific community that branched molecules are more readily
soluble than their aliphatic counterparts; therefore PCLtF will be the focus of crosslinking
studies. In addition to an increased miscibility the branched molecule also provides a greater
crosslinking density wherein the stiffness of the crosslinked material can be increased. The
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inherent miscibility of the synthesized PCL derivatives with the precursor reagent, diethyl
fumarate (DEF), as well as the low molecular weight certain mechanical properties can be
controlled and will be discussed in detail in the proceeding chapter, as well as bulk and rapid
prototyped experiments illustrating the manufacturability of synthesized PCLF/PCLtF.
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CHAPTER 4
BULK AND RP MANUFACTURE OF PCLF/PCLtF CONSTRUCTS
4.1

Introduction
Bulk crosslinking, porogen leaching, and rapid prototype experiments of synthesized

PCLF and PCLtF were conducted as a qualitative examination of successful incorporation of the
photocrosslinkable fumarate group with regards to manufacturability. Several mixtures were
prepared with varying weight percentages of PCLF/PCLtF and diethyl fumarate (DEF) as the
solvent. The addition of 1% (wt%) bis(acyl)phosphine oxide (BAPO) (BASF Corporation,
Florham Park, NJ 07932) as a photoinitiator was added to the mixture to accelerate crosslinking
in bulk crosslinked and porogen leached specimens. An 80%/20% (wt/wt) PCLF/DEF and
PCLtF/DEF with 4 wt% BAPO mixture was used for RP constructs.

4.2

Materials and Methods

4.2.1 Bulk crosslinked specimen preparation
A modified 3mL luer lock syringe (Figure 4.2.1) was used as a cylindrical mold for
photocrosslinking PCLF/DEF and PCLtF/DEF mixtures. The filled syringe was placed in an
ultraviolet oven (ProCure™ 350, 3D Systems, Valencia, CA) and cured for 30 minutes.
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Figure 4.2.1. 3mL luer lock syringe for bulk crosslinking and pH study.

Self supporting crosslinked specimens are shown in Figure 4.2.2. It should be noted that
hydroxyapatite nanoparticles (<200nm) were added at a 0.5 wt% to a PCLtF mixture to illustrate
the possible incorporation of ceramic biocompatible materials within the crosslinked matrix and
its retained photocrosslinkability.

Figure 4.2.2. Bulk crosslinked PCLtF and PCLF self supporting specimens.

4.2.2 Porogen leaching
Porogen leaching is a traditional technique for rendering polymeric materials porous by
suspending a porogen (typically a salt) of a certain particle size within the matrix of
uncrosslinked polymer. The material is then crosslinked (thermally or UV irradiation) to entrap
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the solid porogen particle. In the case of a salt, the solidified material is submerged in distilled
water and the salt is allowed to dissolve.
Porous PCLtF disks were made by the aforementioned traditional technique. 0.5 wt%
sodium chloride (NaCl) (Sigma –Aldrich, St. Louis, MO 63103) crystals of particle size <300
µm were added to an 80/20 (wt/wt) PCLtF/DEF mixture in the presence of 1 wt% BAPO. NaCl
was ground using a pestle and mortar (VWR International, West Chester, PA 19380) and passed
through two sieves (H&C Sieving Systems™, Hogentogler & Co., Inc., Columbia, MD 21046)
with mesh sizes of 710 µm and 300 µm, respectively. Disks of the porogen-containing mixture
were cured as shown in Figure 4.2.3. for an hour and then soaked in distilled water for 3 days
with daily exchange of fresh water.

Porous disks were examined via microcomputed

tomography.

Figure 4.2.3. Bulk crosslinked PCLtF degradation study disk specimen

4.2.3 Three-Dimensional (3D) manufacture of porous disks
The primary goal of the current project is the manufacture of porous 3D scaffolds for
bone regeneration.

The proceeding section aims to explain the experimental design and

procedures for the manufacture of porous PCLtF disks by stereolithography.
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4.2.4 Minitank and Platform
A custom minitank (13.335cm x 13.5cm x 5.715cm) (width x length x depth) and
platform (12.62cm x 8.73cm) (width x length) were fabricated in order to minimize the amount
of synthesized material necessary for subsequent manufacturing experiments.

Figure

4.2.4.illustrates the minitank and platform as it is mounted in the Viper HA SL machine.

Figure 4.2.4. Mounted minitank and platform.

4.2.5 Design of porous disk
A porous disk was designed in a 3D computer-aided design (CAD) package
(ProEngineer® Wildfire® 4.0, Parametric Technology Corp., Needham, MA 02494). Figure 4.2.5
illustrates the designed porous disk used in cell adhesion and biocompatibility studies.
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Figure 4.2.5. Computer-aided designed porous scaffold.

The dimensions of the CAD designed porous disk model are as follows: 25 mm x 3.00
mm (diameter x thickness) and pores of varying sizes (A=0.5mm, B=1mm, and C=2mm). The
diameter was selected so as to fit in a 6-well plate which is used in cell adhesion and
biocompatibility studies

4.2.6 Critical Energy (Ec) and Optical Penetration Depth (Dp)
Two key parameters that affect the overall accuracy of SL manufactured parts are the
critical energy (Ec) (mJ/cm2) and cure depth (Cd) (mm). These two parameters are highly
dependent on the physical properties of the resin. The critical energy is defined as the energy
necessary to solidify the liquid resin where it may be able to withstand some mechanical strain.
The cure depth is the depth to which the resin is cured for the respective Ec. Typically, a
working curve is constructed to determine the optical penetration depth (Dp). A rudimentary trial
and error approach with varying Ec and Dp values was used in the manufacture of the porous
disks. The parameters used in the manufacture of porous PCLtF disks were Ec = 15 mJ/cm2, Dp
= 2.5.
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4.2.7 Manufacturing process of PCLtF porous disks
The following section discusses the fabrication of PCLtF porous disks by
stereolithography.

Figure 4.2.6. Fabrication process of PCLtF porous disk by stereolithography.
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Figure 4.2.6 shows the process by which PCLtF disks were fabricated. Due to the low
energy of the laser (100mW) [76], the photoinitiator (BAPO) concentration was increased to 4
wt% which resulted in an increase in the viscosity of the material. Several attempts were made
to manufacture the porous disk with movement of the platform (z-axis). Therefore, the platform
was manually set slightly below the surface of the resin and deactivated. Disk thickness is a
result of several laser exposures as determined by the number (100) and thickness (30 µm) of
each layer.
Figure 4.2.6a shows the minitank and platform used in building 3D porous PCLtF disks.
It should be noted that modifications to the build platform with regards to hole diameter were
made to the initial platform design (Figure 4.2.4). The original platform was designed with holes
of diameter 0.5mm. The redesigned platform was fabricated with holes of 0.25mm. Preliminary
fabrication experiments using the original platform did not provide adequate support during the
build and draining process resulting in the specimen sinking into the larger sized holes. The
redesigned platform provided better support during fabrication and draining (Figure 4.2.6b).
Fabricated disks were allowed to drain for >15 minutes (Figure 4.2.6c), inverted and
excess PCLtF resin was removed from the underside manually with a spatula. Disks were
transferred to a Petri dish rinsed and soaked in isopropyl alcohol to remove unreacted resin from
the surface and pores of the fabricated part. The disk was then placed on a glass slide (Figure
4.2.6d) and cured in a UV oven for 30 minutes per side. Prior to use in cell adhesion and
biocompatibility studies the disks underwent a cleaning/hydration procedure where the disks
were soaked and shaken for 15 minutes in each of the following solutions: 95% ethanol (v/v),
70% ethanol (v/v), and ultrapure water (Figure 4.2.6e).
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4.3

Results

4.3.1 Porogen leaching
Microcomputed tomography analysis (Scanco USA, Inc., Wayne, PA 19087) of porous
PCLtF disks is shown in Figure 4.3.1. Apparent sedimentation of sodium chloride particles is
evident due to the concentrated porosity at the bottom of the disk. This may be due, in part, to
the low viscosity of the material wherein the suspended sodium chloride during crosslinking (1
hour) matriculated towards the bottom of the mold. These preliminary results indicate the
possibility of employing a traditional porogen leaching technique in an effort to fabricate porous
PCLtF scaffolds.

Figure 4.3.1 Microcomputed tomography 3D reconstruction of porogen leached PCLtF (20 µm voxel size). (A)
50% sagittal cutplane, (B) bottom view illustrating porosity, (C) interface between solid and porous regions, (D)
solid top region.
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4.3.2 RP manufactured porous disks
As stated in the previous section, the ultimate goal of the current project is the
manufacture of porous photocrosslinkable PCL-based scaffolds for hard tissue repair. The
following section presents results of the fabrication of the computer aided designed (CAD)
porous disk (Figure 4.2.5) from synthesized PCLtF. Optical micrographs (Axiovert 40 CFL,
Carl Zeiss Microimaging Inc., Thornwood, NY 10594) of manufactured porous PCLtF were
taken and measured (AxioCam MRc, Carl Zeiss Microimaging Inc., Thornwood, NY 10594)
(Figure 4.3.2).

Figure 4.3.2. Optical micrographs (5x) of SL manufactured porous PCLtF disks.

Figures 4.3.2a and 4.3.2b illustrate the 2mm center pore (Figure 3.6.2) post processed as
described in section 4.2.7. Overcuring of the pore border is evident which resulted in a pore
diameter measurement slightly less than that of the designed part. Also, alterations to the pore

56

dimensions may be affected by swelling and drying of the material as a result of the postprocessing procedure. The pore morphology of the manufactured part appears to corroborate
rather nicely the dimensions of the design. During manufacture and post-processing the material
undergoes expansion and contraction resulting is alterations to the dimensions of the part. This
is evident with the current design. As the pore size decreases (Figures 4.3.2c and 4.3.2d) <1mm
the effect of overcuring is more pronounced. Although the CAD drawing was designed around
the machine limitations it is difficult to theorize the behavior of the material.

4.4

Conclusions
Based on the data presented in this chapter, the proof of concept regarding work

employing a well established polycondensation reaction for the functionalization of
poly(caprolactone)-based biodegradable biomaterials and subsequent manufacture of porous
constructs returned positive results. Although a fully self-supporting 3D construct was not
successfully rapid prototyped, it has been shown that a material can be designed for a particular
rapid prototyping technology; stereolithography in this current work.
Poly(caprolactone) trifumarate was the primary material used in the present work due to
its miscibility with the precursor reagent (DEF), as well as the branched structure providing a
material with a higher crosslinking density; a desirable trait for new biomaterials. It has also
been shown that incorporation of ceramic nanoparticles can be successfully integrated within the
material without impinging on photocrosslinkability/manufacturability.

Scanning electron

micrographs have shown good dispersion of hydroxyapatite nanoparticles within the crosslinked
materials (data not shown). This is important due to the low molecular weight of the synthesized
material and its limited mechanical properties. By incorporating hydroxyapatite nanoparticles
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we are not only able to enhance the mechanical properties of the material, but also render the
material bioactive as previous work conducted in our lab has shown enhanced cell adhesion and
differentiation [77]. The proceeding chapters will discuss the experimental methods and results
of the effect of bulk crosslinked PCLF/PCLtF on a simulated physiological environment, as well
as quantify the degradation rates of particular formulations.
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CHAPTER 5
DEGRADATION AND pH STUDIES
5.1

Introduction
The objective of this study is to examine the effects of crosslinked PCLtF on pH and

determine the degradation rates of bulk crosslinked PCLtF disks with and without hydroxyapatite
(HA) nanoparticles. It is imperative that the integrity of the construct be maintained for a period
of time conducive to tissue ingrowth. Alterations to the surrounding environment of the implant
play a crucial role in the overall success of the material. Therefore, the current experiments
presented in this chapter provide valuable information to be utilized in subsequent cell adhesion
and biocompatibility studies (chapter 6).

5.2

Materials and Methods

5.2.1 pH study
The objective of this study is to examine the effects of crosslinked PCLtF on pH.
Sections of bulk crosslinked PCLtF with and without hydroxyapatite (HA) nanoparticles were
placed in 20 mL scintillation vials containing 10 mL of phosphate-buffered saline (PBS) adjusted
to physiological pH (7.4). Refer to Appendix A for PBS recipe. Three samples of each
respective specimen were used in the present experiment and pH measurements (Orion 720A+,
Thermo Electron Corp., Waltham, MA 02454) were taken in triplicate for statistical analysis.
Figure 5.2.1 illustrates a specimen as it was used in the current experiment. Vials containing pH
specimens were placed in an incubator at 37°C. Washed and unwashed PCLtF specimens were
used in the current experiment for determination of washing protocol efficiency.
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Washed

specimens were soaked in 95% (v/v) ethanol overnight and rinsed with distilled water.
Unwashed specimens were placed in PBS without any post-processing.

Figure 5.2.1. Bulk crosslinked PCLtF section submerged in PBS.

5.2.2 Degradation study
It is imperative that a candidate material for tissue engineering applications be present for
the required amount of time necessary for native tissue growth and degrade in a time frame that
will not impede healing. The objective of this study is to determine the degradation rate of
PCLtF with and without hydroxyapatite. Disks (14mm x 3 mm) were crosslinked in a similar
manner as were pH specimens. Figure 5.2.2 illustrates how the disks were made. Three samples
of each group were used per experiment for statistical analysis. Two batches of PCLtF were
used in this experiment. Batch 1 refers to the initial PCLtF synthesis and batch 2 refers to a
scaled-up synthesis for the purpose of filling the minitank used in the manufacture of porous 3D
disks. Hydroxyapatite nanoparticles-containing specimens were added as an additional group to
determine the effect of HA on the degradation rate. A separate 24-well plate was used for HA
60

and non-HA disks. Disks were weighed on an analytical balance (Pinnacle PI-114, Denver
Instruments, Bohemia, NY 11716) and placed in wells filled with 5mL of PBS stored in an
incubator set at 37°C and 5% CO2. Weekly measurements were taken and the following
equation was used in the determination of % mass loss.

Figure 5.2.2. Bulk crosslinked PCLtF degradation study disk specimen

5.3

Results

5.3.2 pH study
Alterations to the surrounding environment of implanted materials greatly affect the
overall success of the implant. Therefore, the current study was undertaken to examine the effect
of bulk crosslinked PCLtF on physiological pH. Washed (WPCLtF) and unwashed (UWPCLtF)
disks were submerged in PBS adjusted to physiological pH (7.4). Results indicate that washed
specimens with and without hydroxyapatite (HA) minimally affected the simulated physiological
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environment. Figure 5.3.1 is a normalized plot of pH measurements at given time points for the
respective specimens.

Figure 5.3.1. Normalized (7.4) pH study results of washed and unwashed PCLtF disks with and without HA
nanoparticles.

Each sample was run in triplicate and measured at the designated time points shown in
Figure 4.3.2.

The average standard deviation for the respective specimens is:

±0.174

(UWPCLtF), ±0.113 (UWPCLtFHA), ±0.174 (WPCLtF), and ±0.061 (WPCLtFHA). Due to the
scale at which the data is presented and the minimal deviation scale bars were not included.
Based on the data presented it is apparent that washing of the specimen (soaking in 95%
EtOH (v/v) overnight) elicited a positive effect on pH as opposed to unwashed specimens.
Therefore, porous disks will be treated in the same manner prior to cell adhesion and
biocompatibility studies.
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Hydroxyapatite nanoparticles display a stabilizing effect on unwashed PCLtF which may
be attributable to less surface interaction between PCLtF and PBS. HA nanoparticles do not
appear to display the same effect on washed samples which may be a result of the removal of
partially adhered HA nanoparticles from the surface of PCLtF during washing. Initial pH of
washed PCLtF with HA nanoparticles (WPCLtFHA) registered a pH slightly below 7.4 which
may be caused by the aforementioned removal of partially adhered HA nanoparticles.

5.3.3 Degradation study
Results of the degradation study utilizing bulk crosslinked PCLtF disks discussed in the
preceding section are shown in Figure 5.3.2. The respective degradation rate (2.3-5.4% mass
loss per week) of each triplicate sample was calculated by performing linear regression analysis
of the four measured time points. Based on the linearity of curve and a > 0.99 correlation
coefficient we may infer the degradation of each sample to proceed by surface erosion as
opposed to bulk degradation. Plots of bulk degraded materials tend to exhibit an irregular and
non-uniform mass loss plot where as surface eroded materials follow a steady and uniform
degradation such as the one presented.
Degradation of the synthesized photocrosslinkable PCL derivatives is postulated to
proceed by surface erosion as opposed to bulk degradation.

This is due, in part, to a

polydispersity index less than 2 meaning a more uniform molecular chain length and resultant
uniform degradation. During degradation, short oligomeric chains tend to be metabolized first
thus leaving longer polymeric chains [78]. In the case of the synthesized PCL derivatives the
chain lengths are of relative comparable length evident by GPC analysis.
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Figure 5.3.2. Plot of % mass loss and linear regressed degradation rates of PCLtF disks with and without HA
nanoparticles.

As in the previously reported case of the pH study, standard deviations of the respective
triplicate samples were minimal at the scale presented here. Table 5.3.1 displays the initial mass
and average total mass lost (g) per specimen at each given time point.
Table 5.3.1. Table of initial mass and total mass loss per time point.

Specimen
Batch 1 PCLtF
Batch 2 PCLtF
Batch 1
PCLtFHA
Batch 2
PCLtFHA

Mass (g)
(t=0)
689.300
715.467

Mass (g)
lost
(1 week)
19.133
21.967

Mass (g)
lost
(2 weeks)
46.067
64.233

Mass (g)
lost
(3 weeks)
69.433
93.200

Mass (g)
lost
(4 weeks)
89.167
116.500

652.167

30.033

44.500

55.500

65.033

692.433

17.200

44.633

65.333

80.900

The presence of hydroxyapatite (HA) nanoparticles appears to decrease the degradation
rate of crosslinked PCLtF as evident in the slower degradation rates (Figure 5.3.2) and total mass
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loss over the course of the experiment (Table 5.3.1). In addition to stabilizing the pH of the
surrounding environment the effect on degradation rate may be attributable to less exposed
surface area of crosslinked PCLtF. Incorporation of HA nanoparticles may serve a three-fold
benefit in that it has been shown to elicit a positive effect on pH and degradation rate while not
impinging on the crosslinkability of synthesized PCLtF.

5.3.4 Scanning electron microscopy surface evaluation
Surface morphology of degraded PCLtF (Figure 5.3.3a-b) and PCLtFHA (Figure 5.3.3c)
specimens was evaluated by scanning electron microscopy (SEM) (S-4800 UHR FE-SEM,
Hitachi, Pleasanton, CA).
crosslinked disks.

Figures 5.3.3a and 5.3.3b illustrate the top surface of the bulk

Figure 5.3.3c is a cross-sectional view of the inner surface of a bulk

crosslinked PCLtFHA disk.

Texturing and pitting of the outer and inner surface of each

respective sample can be inferred by the SEM micrographs. It is postulated that the mode of
degradation is surface erosion and the micrographs lend themselves to validate that conclusion.
It should be noted that some difficulties were had in obtaining the images and, therefore should
not be viewed as fully accurate representations.
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A

B

C

Figure 5.3.3. Scanning electron micrographs of degraded PCLtF (a & b) and PCLtFHA (c).

5.4

Conclusions
Based on the presented data, it can concluded that synthesized low molecular weight

PCLtF displays properties that support further exploration as a candidate material for tissue
engineering applications. The linearity of the plotted degradation rates (Figure 5.3.2) and SEM
micrographs lead us to postulate the mode of degradation as surface erosion; a desirable
characteristic with regards to bone regeneration. Even though the material is biodegradable
and resorbable it is naïve to assume the material will completely be degraded and expelled by
the physiological system.

A more realistic outcome would involve encapsulation of the

material by deposited mineral over a period of a few months time with eventual tissue
overgrowth incorporating the remaining material.
The steady degradation rate and minimal effect on pH in the washed samples justify
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performing cell adhesion and biocompatibility studies.

As discussed previously, it is

imperative that a candidate material exhibit degredative properties conducive to cell adhesion,
proliferation, and differentiation. The PCLF and PCLtF mixtures used in the current study
display promising degradation rates due to the chemical character of the respective mixtures.
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CHAPTER 6
CELL ADHESION AND BIOCOMPATIBILITY STUDY
6.1

Introduction
This chapter includes general information about rat marrow stromal cells (RMSCs) also

detailed information regarding RMSCs harvest, cell harvesting, aseptic cell culture (primary and
secondary), supplemented media containing osteogenic factors, cell seeding of manufactured
porous poly(caprolactone) trifumarate (PCLtF) disks and in vitro examination of mineralized
nodule formation via fluorescence.

6.2

Materials and Methods

6.2.1 RMSC Harvest and Cell Culture
Five male Wistar rats were humanely euthanized. Bone marrow was harvested from the
respective femora and tibiae of each rat. Surgical instruments were autoclaved prior to use and
were placed in a flask full of 70% (v/v) ethanol to prevent cross-contamination during removal
of bone marrow. The aseptic bone marrow harvest protocol is briefly presented.
First, the fur was disinfected with 70% ethanol (v/v). Sterile scissors were used to
distally reflect the skin from the femur and leg. The reflected skin was removed by manually
displacing the ankle joint and removing the connective tissue in order to remove the foot and
skin. Muscle was removed to expose the hip joint. The hip joint was displaced and the
connective tissue was cut in order to remove the uncompromised femur and leg to prevent
contamination.
Once the legs were aseptically excised, the bones were placed in a sterile biosafety
cabinet and cleaned of muscle and connective tissue. Femora and tibiae were dislocated at the
knee to facilitate bone marrow harvesting. A Petri dish containing 70% ethanol (v/v) was used
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to quickly rinse the bones (less than five seconds). Proximal and distal femora and tibiae were
cut with the bone cutting scissors and the exposed bones were placed in sterile 15mL centrifuge
tubes containing sufficient warm supplemented media (Appendix A) for approximately 30
minutes.
Both legs were excised and each respective pair was placed into the same centrifuge tube.
Additional centrifuge tubes were filled with 5mL of warm supplemented media used to flush out
the bone marrow. This process was performed using an 18G needle attached to a 5mL luer lock
syringe. The same syringe was used to triturate the harvested marrow 5 times in order to break
down the marrow pellet. Triturated bone marrow from each pair of legs was pooled and placed
into T-150 flasks. T-150 flasks were used to provide greater surface area for adhesion and
proliferation. Cell expansion and morphology is shown in Figure 6.2.1.
Non-adherent cells were removed 24 hrs post-harvest. Media was changed every two
days until confluency was achieved. Primary cells were passaged by exposure to trypsin/EDTA
solution on day ten and cryopreserved at a cell density of 1x106 cells/mL (Refer to Appendix B
for protocols).

69

A

B

C

D

Figure 6.2.1. Expansion of RMSCs for subsequent cell seeding experiments

Figure 6.2.1a illustrates the morphology of harvested and thawed RMSCs. After 24
hours of culture, non-adherent cells are removed and adhered cells begin to spread and proceed
to extend processes necessary for cell signaling (Figure 6.2.1b).
magnification optical micrograph of osteo-like cells.

Figure 6.2.1c is a high

The cells are cultured until >80%

confluency is achieved (Figure 6.2.1d) then passaged and cryopreserved or immediately used in
cell adhesion and biocompatibility studies.

6.2.2 Cell seeding of porous PCLtF disks
Cell seeding or the dissemination of cells within a material or on a material’s surface is
the first step in qualitatively and, ultimately, quantitatively examining cell adhesion and
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biocompatibility which may play a critical role in determining the progression of tissue
formation [79]. Post-processed porous PCLtF disks were washed in each of the following
solution: 95% ethanol (v/v), 70% ethanol (v/v), and ultrapure water prior to seeding. Hydrated
PCLtF disks were seeded with RMSCs at a cell density of 2.5 x 105 cells/mL (Figure 6.2.2).
Uniform seeding and distribution of cells may grow more efficiently into uniform tissue, but it
represents a real challenge even for a small scaffold (e.g.5mm diameter X 2mm thick) using a
high concentration solution of cells [80].

Figure 6.2.2. PCLtF disks used in cell adhesion and biocompatibility studies.

6.2.3 Fluorescent examination of mineral deposition in seeded PCLtF disks
A late stage indicator of mature osteoblast culture is mineral deposition. In the case of
osteoblasts, the primary deposited mineral is calcium. A recent study by Wang et. al [81]
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employed two fluorescent calcium chelators as a qualitative examination of deposited
(extracellular) mineralized nodule formation in osteoblastic culture. Data presented by Wang
showed good corroboration between the fluorochromes (Xylenol orange (XO) and Calcein Blue
(CB)) used and two widely used stains (Von Kossa (VK) and Alizarin Red (AR)), as well as
good biocompatibility. Figure 6.2.3 shows the data provided by Wang. The primary benefit of
this procedure is the ability to image living osteoblastic cultures without the necessity of fixation
and ultimate termination of the culture. Xylenol orange (20µM) and calcein blue (30µM)
solutions were prepared as described by Wang et. al. (Appendix A).

Figure 6.2.3. Figure adopted from Wang et al. [81] illustrating concentrations and corroboration of XO and CB
fluorescence with Von Kossa and Alizarin Red staining.
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6.3

Results

6.3.1 Fluorescent examination of mineralization in static RMSC culture
Figure 6.3.1 shows results of fluorescent examination of nodule formation of statically
cultured RMSCs after 14 days culturing.
A

B

C

D

E

Figure 6.3.1. 14 Day post-confluent RMSC culture. Cells were cultured in supplemented media containing xylenol
orange for 24 hours and replaced with fresh media prior to viewing. A) Phase contrast micrograph (5x), B) Dark
field micrograph (5x), C) Fluorescence micrograph (TRITC filter), D) Overlay of (A) and (B), E) Overlay of (A)
and (C).
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This study was performed as a validation of the efficacy of the fluorescence procedure as
it pertains to the current study. Both fluorochromes were used in the current study, but only
xylenol orange (XO) will be employed as a better signal was achieved in comparison to calcein
blue (CB). Figure 6.3.1a is a phase contrast optical micrograph where the dark areas correspond
to postulated deposited mineral (nodules).

Figures 6.3.1b and 6.3.1c are dark field and

fluorescent micrographs of the nodules after exposure to XO. Figures 6.3.1d and 6.3.1e are
overlay images of the phase contrast image and the respective dark field and fluorescence
micrographs. Based on the data presented here we are confident in the fluorescence procedure as
a tool to qualitatively examine nodule formation in mature osteoblast culture.

6.3.2 Cell adhesion and biocompatibility of seeded PCLtF disks
Preliminary results of seeded PCLtF disks manufactured by stereolithography are shown
in Figure 6.3.2. Initial seeding of RMSCs (250,000 cells/mL) on manufactured PCLtF disks
were cultured in a 6-well plate with supplemented media (Figures 6.3.2a – 6.3.2c). Nonadherent cells were removed 24 hours after initial seeding and cell adhesion was noted
predominantly on fibrous PCLtF outgrowings (Figures 6.3.2d – 6.3.2f). A control was run in
conjunction for qualitative examination of confluency (Figure 6.3.2a).
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Figure 6.3.2. . Optical micrographs of PCLtF porous disk seeded with RMSCs.
t=0 hours (a-c) and t=24 hours (d-f).

RMSC seeded PCLtF porous disks at three and five days post-confluency are shown in
Figure 6.3.3.
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Figure 6.3.3. Optical micrographs of PCLtF porous disk seeded with RMSCs. t=3 days (a-c) and t=5 days (d-f).

The top view of a 1mm pore is shown with adhered RMSCs (Figures 6.3.3a (10x) and
6.3.3d (5x)). No noticeable morphological differences can be seen. Middle (Figures 6.6.3b and
6.6.3e) and bottom views (Figures 6.6.3c and 6.6.3f) also illustrate adhered RMSCs. Cell
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spreading and process extension of osteo-like cells can be seen in Figure 6.6.3f where the focal
plane is that of the treated floor of the well-plate. It should also be noted that cell adhesion to the
interior wall of the pore is postulated based on apparent “bridging” of differentiated osteo-like
cells.
A

B

C

D

Figure 6.3.4. Optical micrographs of vacuolization in well containing RMSC-seeded PCLtF porous disks. 7 days
post-confluent (a,b) and 10 days post-confluent (c,d). Surface (b,d) and surrounding area of disk is shown.

6.4

Conclusions
Based on the results presented here it has been shown that manufactured PCLtF porous

disks exhibit good cell adhesion and biocompatibility with regards to cell viability. Certain
limitations exist with the current culture method; namely, adequate replenishment of media
within the pores of the disk. Dynamic cell culturing of 3D constructs through the use of flow
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perfusion bioreactors have illustrated better cell proliferation and differentiation [80, 82-87].
Evaluation of cell adhesion and differentiation on the surface of PCLtF disks proved difficult by
confluence microscopy due to the relative thickness of the manufactured construct. Analysis of
intra-pore cell adhesion and perimeter cell adhesion illustrate positive results. Although slightly
retarded, cell spreading was observed 5 days post-confluence. Fluorescence microscopy results
are forthcoming.
It should be noted that wells containing RMSC-seeded PCLtF porous disks exhibited
vacuolization beginning 7 days post-confluence (Figure 6.3.4). Valerio, et. al. [88] observed
similar vacuolization when osteoblasts were cultured in media containing dissolutioned ceramic
particles consisting primarily of silica.

No reports were found with regards to osteoblast

vacuolization cultured in the presence of Poly(caprolactone) or any derivative thereof. Although
the role of vacuoles in prokaryotic cells varies greatly the consensus is that they serve as
intracellular storage in a support role for other organelles or cells.
According to Valerio, vacuolization did not impede cell adhesion or differentiation.
Increased cell proliferation was enhanced in vacuolized cultures. They also noted an increase in
collagen production in vacuolized osteoblast cultures.

Vacuolization is postulated to be

attributable to the elevated concentration of silica and therefore induces an increased production
of collagen which is resultantly stored within the observed vacuoles.
In regards to the observed vacuolization present in the current study we can only begin to
postulate the formation of vacuoles as a result of the PCLtF disk. Nonetheless, it has been
shown that functionalized photocrosslinkable poly(caprolactone) maintains its well-documented
cell adhesive properties.

78

CHAPTER 7
SUMMARY OF WORK AND RECOMMENDATIONS
7.1

Summary of Work
Poly(caprolactone) (PCL) is a widely used biomaterial in the research arena whose

favorable biological properties have been explored with regards to novel implantable constructs
for tissue engineering and regenerative medicine. The work presented here aimed at addressing
the thesis objectives found in Chapter 1 with regards to further extending the capabilities of PCL
by functionalizing it wherein it is rendered photocrosslinkable resulting in the ability to employ
the rapid prototyping technology, stereolithography, to manufacture three-dimensional (3D)
constructs with controlled geometry for bone regenerative applications.
The methodology adopted in the synthesis of poly(caprolactone) fumarate/trifumarate
(PCLF/PCLtF) is well documented and established, therefore few recommendations will be
suggested with regards to the synthesis. The polycondensation reaction was conducted for the
sole purpose of functionalizing the precursor PCL derivative in order to maintain low molecular
weight products; although the reaction can be employed to increase the chain length and,
resultantly, the molecular weight. No purification of synthesized PCLF/PCLtF was performed.
But, post-processing of cured manufactured parts aimed at removing unreacted resin and
illustrated favorable results in terms of cell adhesion and biocompatibility.
As with all novel biomaterials, adequate chemical, physical, and mechanical
characterization is necessary for appropriate correlations to the desired application.

The

chemical characterizations described in Chapter 3 provide a solid basis with regards to the
application, but more in-depth analysis of the synthesized materials is necessary.
Favorable results involving the manufacture of CAD designed 3D constructs by
stereolithography, as well as bulk crosslinked specimens were discussed in Chapter 4. The
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incorporation of hydroxyapatite (HA) nanoparticles was also shown to not deleteriously affect
photocrosslinkability. Due to the novelty of the material and the specific application in which it
is intended, it is recommended that additional experiments be performed to better characterize
the materials’ physical properties in an effort to address limitations regarding manufacturability
by stereolithography. In addition, further investigations need to be carried out to optimize the
building parameters (dip velocity, pre-dip delay and distance) used in the manufacture of 3D
constructs via stereolithography.
With regards to cell adhesion and biocompatibility, the work presented in Chapter 6
provides a strong basis for continued efforts in the development of PCL-based stereolithography
manufactured 3D constructs. Although promising cell adhesion results were obtained there
appeared to be retardation in differentiation of seeded rat marrow stromal cells (RMSC) and
apparent vacuolization whose cause merits further investigation. This may be due, in part, to the
lack of replenished nutrients during each supplemented media exchange.

Investigations

involving the use of flow perfusion bioreactors of 3D cultured RMSCs may address this delay in
differentiation and maturation.
A patent application is pending with regards to the synthesized materials (PCLF/PCLtF)
and is being guided by the Office of Technology Transfer at the University of Texas at El Paso.

7.2

Recommendations
Although the ultimate goal of this project was not fully achieved, the design and

customization of biomaterials tailored to specific rapid prototyping (RP) technologies has been
shown. The purpose for use of RP technologies in the construction of 3D constructs is two-fold.
The first being customization of implantable constructs for patient-specific injuries and,
secondly, the control of internal and external geometry. A divide exists within the tissue
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engineering community with regards to the necessity of controllable internal geometry and
whether it is necessary for overall success of implanted constructs.

One side contends

controllability of geometry is unnecessary so long as adequate diffusion of nutrients and exposed
surface provide an environment sufficient for cell adhesion and subsequent tissue genesis [5, 89].
On the other hand, another contingency contends that controlled geometry is necessary
not only for enhanced nutrient diffusion [90], but, mechanically speaking, a better tailored
material for a specific application; primarily in applications where stress concentrations may be
impede tissue growth [91, 92]. Porogen-leaching may be useful if an isotropic material is
desired, but in terms of stress concentrations it falls short. RP technologies can address this
limitation through the design and manufacture of anisotropic constructs where directionality is
achieved through the design and manufacture of constructs wherein these bounds are applied. In
addition, the mechanical properties of “soft” materials can be enhanced, as was shown with the
synthesized material, through the incorporation of bioactive ceramic particles.
Due to the manufacturability of the synthesized material and, theoretically speaking, all
materials sharing similar chemical characteristics one should not let themselves believe that only
one mode of manufacturing porous 3D constructs can be used. Perhaps a combination of the two
techniques, traditional and RP, can be employed wherein a porogen is mixed in a SL vat
containing the photocrosslinkable material of choice for the purpose of manufacturing the gross
structure and then subsequently post-processed in order to create the porous internal structure.
I strongly believe that stereolithography (SL) remains a viable technology for the
manufacture of custom implants for regenerative medicine and tissue engineering applications.
Even though much manufacturing success is dependent on the material, I believe that the
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development of novel biomaterials designed specifically to be manufactured by SL is an area that
merits time and effort.
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APPENDIX A
Preparation of Culture Media
α-MEM : Sigma M0644-1L
Slowly add 1 jar of powdered media to ~ 900mL pure water in a 1L beaker, stir with magnetic
stir bar on stir plate (set to around 200rpm) [93]. Rinse jar with a small amount of water (pure)
and add to cylinder. Mix well.
Add 2.2 g/L sodium bicarbonate reagent 99.7-100% 56014-500G pH to 7.0. Bring final volume
up to 1L with pure water. Use this to make other media or sterilize into media bottle and
refrigerate (4°C)
Supplemented Media (15% FBS)
Measure out 340mL culture media.
Add 0.864g sodium-β-glycerophosphate (G9891-100G)
[Sigma glycerol 2-phosphate disodium salt hydrate]
Add 0.02g L-ascorbic acid (sigma A4544-25G)
Filter sterilize with bottle-top filter into autoclaved media bottle.
Add 60mL sterile Fetal bovine serum (FBS) (Sigma F0643)
Add 0.04mL 100 Dexamethasone (97%) (Sigma D4902-100mg)
Add 0.4mL sterile antibiotic stock
Add 0.48mL sterile fungizone, mix well swirl not shake (see Appendix 2)
Store at 4°C
Antibiotic Stock
10mL Normal saline (0.85%)
1.0g penicillin-G (sigma P-3032 100mg/mL)
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0.5g gentamicin sulfate (50mg/mL) (Sigma G-1264)
Filter sterilize with syringe and filter of 0.2μ. Refrigerate 4°C if immediately used, if not, aliquot
in micro centrifuge tubes and store at -20ºC to preserve antibiotics solution in optimal conditions
and avoid wasting the antibiotics. Use 1mL stock in 1L media. Final concentration is 100μg/mL
penicillin and 50μL/mL gentamicin.
Fungizone:
Store sterile fungizone (VWR fungizone SV30078.01) at -20°C.
Aliquot in plastic amber microcentrifuge tubes prior to freezing.
Dexamethasone Stock (100μM)
1.96mg Dexamethason was added to 50mL 100% Ethanol (EtOH) or > 96%
1mL of stock in 1L media for 100nM concentration.
For a 10nM concentration = 1 X 10-8 M you place 1/10mL into 1L this means for every 400mL
of media + FBS you add 40 μL of Dex.
PBS
1 L pure water
0.256 g sodium phosphate, monobasic, monohydrate (NaH2PO4 •H2O)
1.190 g sodium phosphate, dibasic, anhydrate (Na2HPO4)
8.75 g NaCl
Adjust pH to ~ 7.6 with HCl or NaOH
Calcein Blue (30mM)
100mM Potassium hydroxide (KOH) solution was made by adding 28.1mg KOH in 5mL
distilled water.
48.2mg Calcein blue was added to the solution above for the final 30mM stock solution.
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Xylenol Orange (20mM)
71.662mg Xylenol orange was added to 5mL distilled water.
The solution was then filter sterilized using a 0.2µ syringe filter.
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APPENDIX B
Passaging Cells
Cells should be passaged and cryopreserved or reseeded when culture flasks appear to be 80 –
90% confluent. Confluency is a term used to denote when all or most of the available growth
area is occupied by cells. This is an approximate value and depends on the cell type. some cells
are contact inhibited and will stop growing at a certain confluence; others will grow on top of
each other and may align when allowed to overgrow. The procedure used in passaging the cell
cultures used in these experiments is as follows:
1. When flask is nearly 80-90% confluent you will need to passage your cells.
2. Warm 4mL of trypsin/EDTA (0.25%trypsin/0.02%ethylenediaminetetraacetic acid solution)
and medium to 37ºC.
3. Aspirate off old medium.
4. Add 4 – 6mL (or enough volume to cover the growing area) of 1X phosphate buffered saline
(PBS - Appendix A) to rinse the cells. Cells can also be rinsed with 2mL of trypsin/EDTA
solution (quickly) or with medium without serum.
5. Aspirate off the PBS.
6. Add 2 – 4mL of trypsin/EDTA. (2mL for T25 flasks and 4mL for T-75 flasks).
7. Place flask in the incubator for 3 -5 minutes. (4 minutes usually lifts the cells up).
8. Observe the cells at 10X under a microscope. When trypsin is fresh the cells are detached
quickly from the surface through chemical interactions between the cell membrane and
anchoring proteins on the surface of the treated culture flask. Cells may strongly attach to the
flask growing area due to overconfluency the cells or because the trypsin is not fresh. When
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cells are still attached use the palm of your hand perpendicular to the flask and tap the flask to
detach the cells.
9. Observe the flask under the microscope to determine that the cells have lifted off the bottom of
the flask.
10. Add 6mL (T-75) or 3mL (T25) of media containing serum in order to inhibit any further
action of the trypsin/EDTA.
11. Mix the cell suspension by trituration in order to break any clumps.
12. Add 13mL of medium to each new T-75 flask or enough to cover the growing area.
13. Transfer the desired amount of cell suspension to a new T-75 flask. NOTE: if using 10mL
total (4mL of trypsin and 6mL of media), then a 1:3 split would be transferring 3.33mL of
solution to a new T-75 flask.
14. Place flasks in the incubator.
15. Change medium on the flask every 2-3 days. Monitor the flasks at each medium change to
check for contamination, general health, and confluency.

Crypreservation of Cells
Damage to cells can occur from improper cryopreservation as a result of ice crystal formation,
namely alterations in electrolyte concentrations, dehydration, and changes in pH. In order to
minimize the effects of freezing several precautions must be taken, to include:
Use of a cryoprotective agent (DMSO).
Freeze cells at the log phase of growth (stronger and healthier).
Replace media 24 hours before freezing.
Freeze down at a slow rate (1ºC/min this can be done by placing vials in a cryobox
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(Nalgene “Mr. Frosty” ) in the -80ºC freezer)
Procedure:
1. Follow steps 1 – 11 for passaging cells.
2. Transfer the cell suspension to a sterile centrifuge tube
3. Charge hemocytometer to determine the concentration of cells in your cell suspension.
4. Centrifuge at 800 rpm for 5 minutes.
5. While cells are being centrifuged, count the cells in the hemocytometer.
6. Remove tube from centrifuge.
7. Aspirate off medium from centrifuged cells – be careful to avoid the cell pellet.
8. Add enough medium containing 10% DMSO to have a cell suspension of ~106 cells/mL.
9. Break up cell pellet and mix the suspension by drawing the suspension up and down a narrow
mouth pipette.
10. Transfer the cell suspension to cryogenic vials, with 1mL per vial. Make sure to screw the
caps tightly. Label the vials and place them in a cryobox.
11. Place cryobox (Mr. Frosty) in -80ºC freezer for at least 24 hours.
NOTE: Cells could remain at -80ºC for up to ~6 months and still be brought back out. For long
term storage, the cells need to be transferred to -140ºC.
12. Transfer cryogenic vials from cryobox to -140ºC storage.
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